comparemela.com
Home
Live Updates
Sight Sciences Announces the Acceptance for Publication of GEMINI 2, a Three Year, Prospective, Multicenter Trial Demonstrating Sustained, Significant IOP and Medication Reductions Enabled with the OMNI® Surgical System Technology : comparemela.com
Sight Sciences Announces the Acceptance for Publication of GEMINI 2, a Three Year, Prospective, Multicenter Trial Demonstrating Sustained, Significant IOP and Medication Reductions Enabled with the OMNI® Surgical System Technology
Prospective, long-term trial results are consistent with the significant body of published clinical evidence demonstrating the durable safety and effectiveness of procedures enabled with the OMNI...
Related Keywords
Oklahoma ,
United States ,
Texas ,
Stevenr Sarkisian Jr ,
Paul Badawi ,
Afua Ohene Nyako ,
Jaimee Dickerson Jr ,
Steve Sarkisian ,
Philip Taylor ,
Michaeld Greenwood ,
Sight Sciences Inc ,
Nasdaq ,
Texas Health Science Center ,
Securities Exchange ,
Falcon Vision ,
Globenewswire Inc ,
Omni Eye Services ,
Gilmartin Group ,
Company Tearcare ,
Sight Sciences ,
Ophthalmology Associates ,
Glaukos Corporation ,
Clinical Ophthalmology ,
Surgical System ,
Micro Invasive Glaucoma Surgery ,
Thompson Vision ,
Oklahoma Eye Surgeons ,
Month Outcomes ,
Trabeculotomy Combined ,
Cataract Surgery ,
Primary Open Angle ,
Surgical Instrument ,
Securities Act ,
Securities Exchange Act ,
Private Securities Litigation Reform Act ,
Markets ,
comparemela.com © 2020. All Rights Reserved.